147 related articles for article (PubMed ID: 21502678)
1. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
Yi Z; Jie YW; Nan Z
Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
[TBL] [Abstract][Full Text] [Related]
5. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.
Chuang TW; Hung CH; Huang SC; Lee CM
J Formos Med Assoc; 2007 Oct; 106(10):869-73. PubMed ID: 17964968
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Long-Term Corticosteroid Monotherapy in 26 Cases of Nephrotic Syndrome with Biopsy-Proven Membranous Nephropathy Induced by Seronegative Hepatitis B Virus-Associated Glomerulonephritis.
Zhang Y; Chen S; Yang D; Liu J; Zhang X; Yang X; Han H; Yang D
Nephron; 2021; 145(2):113-122. PubMed ID: 33561853
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Zhang Y; Zhou JH; Yin XL; Wang FY
World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
[TBL] [Abstract][Full Text] [Related]
11. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
Yang YF; Xiong QF; Zhao W; Zhong YD
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine in hepatitis B-associated membranous nephropathy.
Tang S; Lai FM; Lui YH; Tang CS; Kung NN; Ho YW; Chan KW; Leung JC; Lai KN
Kidney Int; 2005 Oct; 68(4):1750-8. PubMed ID: 16164651
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
Xiong QF; Zhong YD; Hu ZL; Yang YF
Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
Sun LJ; Shan JP; Cui RL; Yuan WJ; Jiang GR
Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B-related glomerulonephritis and optimization of treatment.
Liu Y; Shi C; Fan J; Wang B; Li G
Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):113-125. PubMed ID: 31951758
[No Abstract] [Full Text] [Related]
17. [Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].
Lu HY; Zhuang LW; Yu YY; Si CW; Li J
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):198-202. PubMed ID: 18364079
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
[TBL] [Abstract][Full Text] [Related]
19. Phyllanthus species for chronic hepatitis B virus infection.
Xia Y; Luo H; Liu JP; Gluud C
Cochrane Database Syst Rev; 2011 Apr; (4):CD008960. PubMed ID: 21491412
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
